Intestifalk

Budesonide, the active ingredient in Intestifalk, is a corticosteroid presented as a rectal formulation for rectal use. It treats ulcerative colitis by reducing inflammation in the colon and rectal mucosa.\n\nGNH India supplies Intestifalk as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Intestifalk is a locally acting corticosteroid used in the management of ulcerative colitis and related distal disease.\n\nUlcerative colitis: reduces inflammation in the colon to induce remission.\nUlcerative proctitis: provides targeted anti‑inflammatory effect in the rectum.\nDistal ulcerative colitis: helps control symptoms and maintain mucosal healing.

Intestifalk may cause a range of adverse reactions, most of which are mild and reversible.\n\nCommon Side Effects:\n- Rectal irritation or burning sensation\n- Abdominal discomfort or cramping\n- Nausea or mild headache\n- Transient increase in bowel movements\n- Localized fungal infection (candidiasis)\n\nSerious or Rare Side Effects:\n- Severe allergic reaction (anaphylaxis)\n- Systemic corticosteroid effects such as adrenal suppression\n- Persistent infection or worsening colitis\n- Significant rise in intra‑ocular pressure\n- Rare cases of perforated colon

Before using Intestifalk, consider the following safety measures.\n\nPregnancy: consult a healthcare professional; benefits must outweigh potential risks.\nBreastfeeding: discuss with a physician as drug may pass into milk.\nInfection risk: avoid use if active systemic infection is present.\nImmunosuppression: monitor patients with compromised immune systems.\nConcomitant steroids: limit combined systemic corticosteroid exposure.\nStore at room temperature: keep in the original packaging, protect from moisture and heat.

Intestifalk can interact with other medicines, requiring careful management.\n\nMajor Interactions (Avoid):\n- Systemic corticosteroids: may increase risk of adrenal suppression.\n- CYP3A4 inhibitors (e.g., ketoconazole): can raise budesonide levels.\n\nModerate Interactions (Monitor Closely):\n- Antifungal agents (e.g., fluconazole): may modestly increase exposure.\n- Anticoagulants (e.g., warfarin): monitor for altered bleeding risk.\n- Immunosuppressants (e.g., azathioprine): watch for additive infection risk.